Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

474.62
-9.3900-1.94%
Post-market: 474.620.00000.00%19:58 EDT
Volume:2.88M
Turnover:1.39B
Market Cap:121.88B
PE:-228.18
High:499.07
Open:484.35
Low:473.64
Close:484.01
Loading ...

11 Stocks to Buy After the Biotech Bloodbath -- Barrons.com

Dow Jones
·
Yesterday

Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know

Zacks
·
Yesterday

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

StockStory
·
03 Apr

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Gene-Editing Stock to Buy?

Insider Monkey
·
02 Apr

Vertex Pharmaceuticals Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
02 Apr

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates

Zacks
·
01 Apr

RBC Adjusts Price Target on Vertex Pharmaceuticals to $420 From $408, Maintains Sector Perform Rating

MT Newswires Live
·
01 Apr

BUZZ-RBC raises Vertex PT, expects strong start for cystic fibrosis drug

Reuters
·
01 Apr

Vertex Pharmaceuticals Inc : RBC Raises Target Price to $420 From $408

THOMSON REUTERS
·
01 Apr

Vertex Pharmaceuticals (VRTX) Gets a Hold from Bernstein

TIPRANKS
·
01 Apr

Evercore ISI Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
01 Apr

Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
01 Apr

Intellia Focuses on Pipeline Development Amid Stiff Competition

Zacks
·
31 Mar

Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”

Insider Monkey
·
31 Mar

Vertex Pharmaceuticals Is Maintained at Buy by B of A Securities

Dow Jones
·
31 Mar

Vertex Pharmaceuticals Inc : Bofa Global Research Raises Price Objective to $567 From $555

THOMSON REUTERS
·
31 Mar

Vertex Pharmaceuticals Ends VX-264 Study in Diabetes After Failing to Meet Efficacy Endpoint

MT Newswires Live
·
31 Mar

Vertex Pharmaceuticals’ Journavx: Strong Demand and Positive Outlook Drive Buy Rating

TIPRANKS
·
31 Mar

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

ACCESS Newswire
·
31 Mar